Symbol="EQRX"
AssetType="Common Stock"
Name="EQRx Inc"
Description="EQRx, Inc., a pharmaceutical company, is engaged in the development of drugs primarily for the treatment of cancer and immuno-inflammatory diseases in the United States. The company is headquartered in Cambridge, Massachusetts."
CIK="1843762"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="C/O CORVEX MANAGEMENT LP, 667 MADISON AVENUE, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="979592000"
EBITDA="-367683008"
PERatio="None"
PEGRatio="None"
BookValue="2.733"
DividendPerShare="0"
DividendYield="0"
EPS="-0.58"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.151"
ReturnOnEquityTTM="-0.19"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.58"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="2.55"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.998"
EVToRevenue="-"
EVToEBITDA="0.281"
Beta="0.643"
num_52WeekHigh="6.05"
num_52WeekLow="1.58"
num_50DayMovingAverage="1.793"
num_200DayMovingAverage="2.738"
SharesOutstanding="487359000"
DividendDate="None"
ExDividendDate="None"
symbol="EQRX"
open="2.01"
high="2.07"
low="1.99"
price="2.03"
volume="864407.00"
latest_trading_day="2023-07-11"
previous_close="2.01"
change="0.02"
change_percent="0.9950%"
aroon_positive_momentum_days="10"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="10"
Volume_recent_avg="2153977"
Change_recent_avg="0.01"
Delta_recent_avg="0.11"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.11"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="10"
Aroon_momentum_negative="90"
image_negative_thumbnail_id_1="1157"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0191.jpeg"
image_negative_thumbnail_id_2="1147"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0180.jpeg"
image_neutral_thumbnail_id_1="536"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0063.jpeg"
image_neutral_thumbnail_id_2="564"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0035.jpeg"
image_positive_thumbnail_id_1="671"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0037.jpeg"
image_positive_thumbnail_id_2="618"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0090.jpeg"
image_professor_thumbnail_id_1="1182"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
